Identification of oxazolo[4,5-g]quinazolin-2(1H)-one Derivatives as EGFR Inhibitors for Cancer Prevention.
Renganthan SenthilKishore Kumar Meenakshi SundaramGiridharan BupeshSingaravelu UshaSaravanan Konda ManiPublished in: Asian Pacific journal of cancer prevention : APJCP (2022)
Thus, the results obtained from this research provide insights for the development of oxazolo[4,5-g]quinazoline-2(1H)-one derivative as potent EGFR inhibitors.